Truist Financial Corp Sells 5,841 Shares of HCA Healthcare, Inc. $HCA

Truist Financial Corp cut its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 2.1% in the fourth quarter, Holdings Channel.com reports. The institutional investor owned 274,057 shares of the company’s stock after selling 5,841 shares during the period. Truist Financial Corp’s holdings in HCA Healthcare were worth $127,946,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently bought and sold shares of the stock. Sovran Advisors LLC lifted its position in HCA Healthcare by 1.0% in the third quarter. Sovran Advisors LLC now owns 2,278 shares of the company’s stock worth $1,063,000 after buying an additional 22 shares during the last quarter. Centerpoint Advisors LLC increased its position in HCA Healthcare by 11.0% during the third quarter. Centerpoint Advisors LLC now owns 222 shares of the company’s stock valued at $95,000 after acquiring an additional 22 shares during the last quarter. Cary Street Partners Financial LLC increased its position in HCA Healthcare by 3.9% during the third quarter. Cary Street Partners Financial LLC now owns 590 shares of the company’s stock valued at $251,000 after acquiring an additional 22 shares during the last quarter. Angeles Wealth Management LLC increased its position in HCA Healthcare by 2.4% during the third quarter. Angeles Wealth Management LLC now owns 1,014 shares of the company’s stock valued at $432,000 after acquiring an additional 24 shares during the last quarter. Finally, One Capital Management LLC increased its position in HCA Healthcare by 1.1% during the third quarter. One Capital Management LLC now owns 2,250 shares of the company’s stock valued at $959,000 after acquiring an additional 24 shares during the last quarter. Hedge funds and other institutional investors own 62.73% of the company’s stock.

Insider Buying and Selling

In other news, SVP Jennifer Berres sold 8,020 shares of HCA Healthcare stock in a transaction on Wednesday, February 11th. The stock was sold at an average price of $514.58, for a total value of $4,126,931.60. Following the transaction, the senior vice president directly owned 11,993 shares in the company, valued at approximately $6,171,357.94. This trade represents a 40.07% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, EVP Michael S. Cuffe sold 1,500 shares of HCA Healthcare stock in a transaction on Tuesday, February 3rd. The shares were sold at an average price of $498.09, for a total value of $747,135.00. Following the completion of the transaction, the executive vice president owned 30,003 shares in the company, valued at $14,944,194.27. This represents a 4.76% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last 90 days, insiders have sold 15,214 shares of company stock valued at $7,797,595. 1.50% of the stock is owned by insiders.

HCA Healthcare Stock Up 0.1%

Shares of NYSE HCA opened at $433.73 on Monday. The business has a fifty day simple moving average of $497.66 and a two-hundred day simple moving average of $486.41. The firm has a market cap of $96.50 billion, a PE ratio of 14.92, a price-to-earnings-growth ratio of 1.37 and a beta of 1.19. HCA Healthcare, Inc. has a twelve month low of $330.00 and a twelve month high of $556.52.

HCA Healthcare (NYSE:HCA) last issued its earnings results on Friday, April 24th. The company reported $7.15 earnings per share for the quarter, missing analysts’ consensus estimates of $7.19 by ($0.04). The firm had revenue of $19.11 billion for the quarter, compared to the consensus estimate of $19.09 billion. HCA Healthcare had a net margin of 8.89% and a negative return on equity of 295.93%. The company’s revenue for the quarter was up 4.3% on a year-over-year basis. During the same period last year, the firm earned $6.45 earnings per share. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. On average, research analysts expect that HCA Healthcare, Inc. will post 30.05 earnings per share for the current year.

HCA Healthcare Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, June 30th. Stockholders of record on Tuesday, June 16th will be issued a $0.78 dividend. The ex-dividend date is Tuesday, June 16th. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.7%. HCA Healthcare’s dividend payout ratio (DPR) is currently 10.73%.

Wall Street Analysts Forecast Growth

A number of brokerages recently issued reports on HCA. Oppenheimer decreased their price target on HCA Healthcare from $540.00 to $520.00 and set an “outperform” rating for the company in a research note on Monday, April 27th. Barclays decreased their price target on HCA Healthcare from $551.00 to $496.00 and set an “overweight” rating for the company in a research note on Monday, April 27th. Argus raised their price target on HCA Healthcare from $530.00 to $560.00 and gave the stock a “buy” rating in a research note on Friday, February 6th. Weiss Ratings reissued a “buy (b)” rating on shares of HCA Healthcare in a research report on Friday, March 27th. Finally, Robert W. Baird lowered their price objective on shares of HCA Healthcare from $450.00 to $442.00 and set a “neutral” rating for the company in a research report on Wednesday, April 15th. Sixteen analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, HCA Healthcare currently has an average rating of “Moderate Buy” and an average price target of $520.55.

HCA Healthcare Company Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.